Abstract
Upon the entry of nutrients into the small intestine, nutrient sensing mechanisms are activated to allow the body to adapt appropriately to the incoming nutrients. To date, mounting evidence points to the existence of an upper intestinal lipid-induced gut–brain neuronal axis to regulate energy homeostasis. Moreover, a recent discovery has also revealed an upper intestinal lipid-induced gut–brain–liver neuronal axis involved in the regulation of glucose homeostasis. In this mini-review, we will focus on the mechanisms underlying the activation of these respective neuronal axes by upper intestinal lipids.
Similar content being viewed by others
References
Cummings DE, Overduin J (2007) Gastrointestinal regulation of food intake. J Clin Invest 117:13–23
Wang PY, Caspi L, Lam CK, Chari M, Li X, Light PE, Gutierrez-Juarez R, Ang M, Schwartz GJ, Lam TK (2008) Upper intestinal lipids trigger a gut–brain–liver axis to regulate glucose production. Nature 452:1012–1016
Matzinger D, Degen L, Drewe J, Meuli J, Duebendorfer R, Ruckstuhl N, D’Amato M, Rovati L, Beglinger C (2000) The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut 46:688–693
Feinle C, O’Donovan D, Doran S, Andrews JM, Wishart J, Chapman I, Horowitz M (2003) Effects of fat digestion on appetite, APD motility, and gut hormones in response to duodenal fat infusion in humans. Am J Physiol Gastrointest Liver Physiol 284:G798–G807
Greenberg D, Smith GP, Gibbs J (1990) Intraduodenal infusions of fats elicit satiety in sham-feeding rats. Am J Physiol 259:R110–R118
Lieverse RJ, Jansen JB, Masclee AA, Rovati LC, Lamers CB (1994) Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide. Gut 35:501–505
Matzinger D, Gutzwiller JP, Drewe J, Orban A, Engel R, D’Amato M, Rovati L, Beglinger C (1999) Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans. Am J Physiol 277:R1718–R1724
Covasa M, Ritter RC (2001) Attenuated satiation response to intestinal nutrients in rats that do not express CCK-A receptors. Peptides 22:1339–1348
Feltrin KL, Little TJ, Meyer JH, Horowitz M, Rades T, Wishart J, Feinle-Bisset C (2007) Effects of lauric acid on upper gut motility, plasma cholecystokinin and peptide YY, and energy intake are load, but not concentration, dependent in humans. J Physiol 581:767–777
Schwartz GJ, Whitney A, Skoglund C, Castonguay TW, Moran TH (1999) Decreased responsiveness to dietary fat in Otsuka Long-Evans Tokushima fatty rats lacking CCK-A receptors. Am J Physiol 277:R1144–R1151
Feltrin KL, Little TJ, Meyer JH, Horowitz M, Smout AJ, Wishart J, Pilichiewicz AN, Rades T, Chapman IM, Feinle-Bisset C (2004) Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length. Am J Physiol Regul Integr Comp Physiol 287:R524–R533
McLaughlin J, Grazia LM, Jones MN, D’Amato M, Dockray GJ, Thompson DG (1999) Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology 116:46–53
Moran TH, Kinzig KP (2004) Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol 286:G183–G188
Cox JE (1996) Effect of pyloric cuffs on cholecystokinin satiety. Physiol Behav 60:1023–1026
Gibbs J, Young RC, Smith GP (1973) Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature 245:323–325
Gibbs J, Falasco JD, McHugh PR (1976) Cholecystokinin-decreased food intake in rhesus monkeys. Am J Physiol 230:15–18
Kissileff HR, Pi-Sunyer FX, Thornton J, Smith GP (1981) C-terminal octapeptide of cholecystokinin decreases food intake in man. Am J Clin Nutr 34:154–160
Kraly FS, Carty WJ, Resnick S, Smith GP (1978) Effect of cholecystokinin on meal size and intermeal interval in the sham-feeding rat. J Comp Physiol Psychol 92:697–707
Moran TH, Ameglio PJ, Schwartz GJ, McHugh PR (1992) Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK. Am J Physiol 262:R46–R50
Moran TH, Baldessarini AR, Salorio CF, Lowery T, Schwartz GJ (1997) Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin. Am J Physiol 272:R1245–R1251
Weatherford SC, Chiruzzo FY, Laughton WB (1992) Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice. Am J Physiol 262:R574–R578
Woltman T, Castellanos D, Reidelberger R (1995) Role of cholecystokinin in the anorexia produced by duodenal delivery of oleic acid in rats. Am J Physiol 269:R1420–R1433
Monnikes H, Lauer G, Bauer C, Tebbe J, Zittel TT, Arnold R (1997) Pathways of Fos expression in locus ceruleus, dorsal vagal complex, and PVN in response to intestinal lipid. Am J Physiol 273:R2059–R2071
Berthoud HR, Patterson LM (1996) Anatomical relationship between vagal afferent fibers and CCK-immunoreactive entero-endocrine cells in the rat small intestinal mucosa. Acta Anat (Basel) 156:123–131
Moran TH, Smith GP, Hostetler AM, McHugh PR (1987) Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches. Brain Res 415:149–152
Moran TH, Norgren R, Crosby RJ, McHugh PR (1990) Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers. Brain Res 526:95–102
Sclafani A, Ackroff K, Schwartz GJ (2003) Selective effects of vagal deafferentation and celiac-superior mesenteric ganglionectomy on the reinforcing and satiating action of intestinal nutrients. Physiol Behav 78:285–294
Hansen HS, Diep TA (2009) N-acylethanolamines, anandamide and food intake. Biochem Pharmacol [Epub ahead of print]
Schwartz GJ, Fu J, Astarita G, Li X, Gaetani S, Campolongo P, Cuomo V, Piomelli D (2008) The lipid messenger OEA links dietary fat intake to satiety. Cell Metab 8:281–288
de Kloet AD, Woods SC (2009) Minireview: endocannabinoids and their receptors as targets for obesity therapy. Endocrinology 150:2531–2536
Gomez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del AI, Cippitelli A, Nava F, Piomelli D, Rodriguez de FF (2002) A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 22:9612–9617
Burdyga G, Lal S, Varro A, Dimaline R, Thompson DG, Dockray GJ (2004) Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin. J Neurosci 24:2708–2715
Thabuis C, Tissot-Favre D, Bezelgues JB, Martin JC, Cruz-Hernandez C, Dionisi F, Destaillats F (2008) Biological functions and metabolism of oleoylethanolamide. Lipids 43:887–894
Obici S, Zhang BB, Karkanias G, Rossetti L (2002) Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8:1376–1382
Obici S, Feng Z, Morgan K, Stein D, Karkanias G, Rossetti L (2002) Central administration of oleic acid inhibits glucose production and food intake. Diabetes 51:271–275
Pocai A, Lam TK, Gutierrez-Juarez R, Obici S, Schwartz GJ, Bryan J, Aguilar-Bryan L, Rossetti L (2005) Hypothalamic K (ATP) channels control hepatic glucose production. Nature 434:1026–1031
Obici S, Feng Z, Arduini A, Conti R, Rossetti L (2003) Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 9:756–761
Pocai A, Obici S, Schwartz GJ, Rossetti L (2005) A brain–liver circuit regulates glucose homeostasis. Cell Metab 1:53–61
Lam TK, Pocai A, Gutierrez-Juarez R, Obici S, Bryan J, Aguilar-Bryan L, Schwartz GJ, Rossetti L (2005) Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat Med 11:320–327
Caspi L, Wang PY, Lam TK (2007) A balance of lipid-sensing mechanisms in the brain and liver. Cell Metab 6:99–104
He W, Lam TK, Obici S, Rossetti L (2006) Molecular disruption of hypothalamic nutrient sensing induces obesity. Nat Neurosci 9:227–233
Covasa M, Ritter RC (1999) Reduced sensitivity to the satiation effect of intestinal oleate in rats adapted to high-fat diet. Am J Physiol 277:R279–R285
Covasa M, Grahn J, Ritter RC (2000) Reduced hindbrain and enteric neuronal response to intestinal oleate in rats maintained on high-fat diet. Auton Neurosci 84:8–18
Artmann A, Petersen G, Hellgren LI, Boberg J, Skonberg C, Nellemann C, Hansen SH, Hansen HS (2008) Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta 1781:200–212
Izzo AA, Piscitelli F, Capasso R, Aviello G, Romano B, Borrelli F, Petrosino S, Di MV (2009) Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. Br J Pharmacol [Epub ahead of print]
Acknowledgments
T. Lam is supported by grants from the Canadian Institutes of Health Research (CIHR, MOP-82701 and 86554). G. Cheung is supported by a graduate studentship from the Banting and Best Diabetes Centre at the University of Toronto (BBDC). A. Kokorovic is supported by a grant from the BBDC. T. Lam holds the John Kitson McIvor Chair in Diabetes Research at the Toronto General Research Institute and the University of Toronto. We apologize to colleagues whose work has not been specifically referenced due to space limitations.
Author information
Authors and Affiliations
Corresponding author
Additional information
G. W. C. Cheung and A. Kokorovic contributed equally to this review.
Rights and permissions
About this article
Cite this article
Cheung, G.W.C., Kokorovic, A. & Lam, T.K.T. Upper intestinal lipids regulate energy and glucose homeostasis. Cell. Mol. Life Sci. 66, 3023–3027 (2009). https://doi.org/10.1007/s00018-009-0062-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-009-0062-y